Trade ZLAB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Zai Lab Limited American Depositary Shares (ZLAB) is trading at US$26.13, down 2.57% today as of Aug 28, 09:45 EDT. The company has a market capitalisation of US$2.92B. Over the past 52 weeks, ZLAB has traded between US$15.96 and US$34.72. On Syfe you can trade ZLAB with $0 commission and add it to your watchlist.
| Previous close | US$26.82 |
|---|---|
| Market cap | US$2.92B |
| 52-week range | US$15.96 – US$34.72 |
| Volume | 595.32K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Zai Lab Limited American Depositary Shares
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Year: 2017
Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing
Jun 29, 8:24 PM · MT Newswires
Stay on top of ZLAB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
